Weight Loss at the Spa at West Glen
Semaglutide and Tirzepatide in Des Moines, IA
FAQS
What is Semaglutide and Tirzepatide:
Semaglutide is a revolutionary GLP-1 receptor agonist that was originally developed for patients with Type 2 diabetes, but when providers and pharmaceutical developers noticed how much weight their patients were losing, they began to study Semaglutide exclusively for weight loss. A series of clinical trials known as the STEP clinical trials deomstrated that almost 90% of patients lost 5% or more of their body weight. In June of 2022, the FDA approved Semaglutide for weight loss.
How does Semaglutide/ Tirzepatide work?
These medications work to:
-increase insulin production
-decrease glucagon synthesis
-delay gastric emptying
-suppress hunger. It signals your brain that you are full so you can lose weight without feeling like you are depriving yourself.
What are potential side effects?
-Commonly reported GI side effects- nausea, vomiting, diarrhea, constipation, abdominal pain.
-Site reactions
-Fatigue
-Headaches
-Alcohol intolerance
Under 18 years old
Pregnant/breastfeeding
Type 1 diabetes mellitus
Diabetes ketoacidosis
Hypersensitivity to Semaglutide/Tirzepatide or any components of these medications
Personal or family history of medullary thyroid carcinoma
History of multiple endocrine neoplasia syndrome
History of pancreatitis
End stage renal disease (on dialysis)
BMI <25
Patients with diabetic retinopathy
Who is NOT a candidate for Weight loss at The Spa at West Glen?
Who IS a candidate?
-Everyone else*
**Health history, medications and body weight information will be carefully reviewed by a licensed provider to determine each candidate’s eligibility.